Profil bibliographique

Thubeena Manickavasagar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

48Publications signalées

218Citations signalées

3Affiliations récentes

Les institutions déclarées

Royal Marsden NHS Foundation Trust King's College London Royal Marsden Hospital

Les domaines associés

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis

Les publications récentes

Accès ouvert 2026 article OpenAlex

Unilateral Scleral Icterus as a Rare Presentation of Choroidal Metastasis in Transdifferentiated EGFR-Mutant Lung Cancer: A Case Report and Review of the Literature

Oz Levinkron, Thubeena Manickavasagar, Sanjay Popat, Richard Scawn

gb (code pays fourni par la source)

0 citations Lung Cancer Targets and Therapy

2026 article OpenAlex

“Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers”: Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets

David König, Thubeena Manickavasagar, Dharmisha Chauhan, Sanjay Popat

gb (code pays fourni par la source)

0 citations Journal of Thoracic Oncology

2026 conference-abstract OpenAlex

P211 Infection risk and clinical outcomes in immune checkpoint inhibitor–induced colitis

Dhruv Shah, Hajir Ibraheim, Paolo D. d’Arienzo, Nathan James Dean et autres

gb (code pays fourni par la source)

0 citations E-Posters

Accès ouvert 2026 article OpenAlex

Impact of concurrent colonic CMV infection on clinical outcomes in immune checkpoint inhibitor–induced colitis

Hajir Ibraheim, Paolo D. d’Arienzo, Nathan James Dean, William Duggleby et autres

gb, ca (code pays fourni par la source)

0 citations European Journal of Cancer

Accès ouvert 2026 review OpenAlex

Renal medullary carcinoma: a systematic review of clinical and radiological findings

William B. N. Weston, Cherry Sit, Derfel ap Dafydd, Christian Kelly-Morland et autres

gb, nl (code pays fourni par la source)

1 citation International Urology and Nephrology

Accès ouvert 2026 article OpenAlex

Independent Testing of Published CT Models for PD-L1 Status in Non–Small Cell Lung Cancer

Robert O’Shea, Carolyn Anne Kirby Horst, Thubeena Manickavasagar, E. Josephides et autres

gb (code pays fourni par la source)

0 citations Radiology

2026 article OpenAlex

216 The efficacy and safety of the use of postoperative radiation therapy, in thymic tumours: a tertiary centre retrospective analysis

Foteini Kalofonou, Thubeena Manickavasagar, Merina Ahmed, Sabiq Dipro et autres

gb (code pays fourni par la source)

0 citations Lung Cancer

2026 article OpenAlex

299 A phase I/II study to evaluate EP0031 (lunbotinib), a next generation selective RET inhibitor, as monotherapy and in combination with chemotherapy, in patients with advanced RET fusion positive NSCLC

Martin G. Forster, Sanjay Popat, Debashis Sarker, Jonathan Wadsley et autres

gb (code pays fourni par la source)

0 citations Lung Cancer

2026 conference-abstract OpenAlex

DOP070 Endoscopic phenotypes predict outcomes and align with transcriptomic profiles in immune checkpoint inhibitor–induced colitis: A multicentre cohort study

H Ibraheim, P. D’Arienzo, N Dean, Thubeena Manickavasagar et autres

gb (code pays fourni par la source)

0 citations Journal of Crohn s and Colitis

Accès ouvert 2026 preprint OpenAlex

Impact of concurrent CMV colitis on clinical outcomes in immune checkpoint inhibitor‒induced colitis

Hajir Ibraheim, Paolo D. d’Arienzo, Nathan James Dean, William Duggleby et autres

gb (code pays fourni par la source)

0 citations SSRN Electronic Journal

Accès ouvert 2025 article OpenAlex

PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer

D.J. Hughes, Gitasha Chand, Jessica Johnson, Ronan Tegala et autres

gb (code pays fourni par la source)

4 citations British Journal of Cancer

Accès ouvert 2025 article OpenAlex

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres

gb, it (code pays fourni par la source)

5 citations JAMA Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.